gw501516 

GW-501516 or Cardarine(1) as it’s called was developed in the 1990s by a joint effort of two pharmaceuticals powerhouses GlaxoSmithKline and Ligand Pharmaceuticals. Originally set in motion at clinical developmental stages as a drug to forestall cardiovascular diseases especially tumor formation in different parts of the body like breasts, colon, and prostate. Visit https://www.restoreunity.org/gw-501516-cardarine/